Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Photo

Borderline pulmonary arterial pressure (BoPAP) in systemic sclerosis patients: a post-hoc analysis of the DETECT study.

pulmonary hypertension

  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,610 posts
  • Location:West Sussex

Posted 23 January 2015 - 09:22 AM

Borderline pulmonary arterial pressure (BoPAP) in systemic sclerosis patients: a post-hoc analysis of the DETECT study.

 

In this exploratory post–hoc analysis of the DETECT study population patients with BoPAP could be distinguished from patients with normal mean pulmonary artery pressures and pulmonary arterial hypertension. PubMed, Arthritis Res Ther, 2014 Dec 10;16(6):493. (Also see: Pulmonary Hypertension)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)